Biologic Treatment
Mostrando 1-12 de 112 artigos, teses e dissertações.
-
1. First-line biologic therapy with tumor necrosis factor inhibitors for psoriatic arthritis: a prospective observational study
ABSTRACT BACKGROUND: Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects multiple joints. It is associated with psoriasis and treated with synthetic and biologic drugs. OBJECTIVE: The objective of this study was to assess the outcomes of patients who received biologic therapy with tumor necrosis factor (TNF) inhibitors in terms of effe
Sao Paulo Medical Journal. Publicado em: 2022
-
2. Pavonia Cav. SPECIES (MALVACEAE SENSU LATO) AS SOURCE OF NEW DRUGS: A REVIEW
Pavonia Cav., is a genus in the Malvaceae sensu lato family, containing 271 species with worldwide distribution, although with a higher diversity in America and Asia. Species from this genus are traditionally used in folk medicine with several biological activities, arousing scientific interest on the search for the substances responsible for such activities
Química Nova. Publicado em: 2022
-
3. BIOLOGICAL THERAPY PENETRATION FOR INFLAMMATORY BOWEL DISEASE IN LATIN AMERICA: CURRENT STATUS AND FUTURE CHALLENGES
RESUMO CONTEXTO: A introdução dos agentes anti-TNF representou um marco no tratamento da doença de Crohn (DC) e da recocolite ulcerativa (RCU), com maior eficácia e segurança quando comparado ao tratamento convencional. No entanto, ainda existem desafios significativos na América Latina para facilitar o acesso dos agentes biológicos a médicos e pac
Arq. Gastroenterol.. Publicado em: 30/09/2019
-
4. Central nervous system and analgesic profiles of Lippia genus
Abstract Many people use medicinal plants to relieve disorders related to the central nervous system, such as depression, epilepsy, anxiety and pain, even though the effectiveness of most of them has not yet been proven through scientific studies. Plants of the Lippia genus, Verbenaceae, are widely used in ethnobotany as a food, for seasoning and in antisept
Rev. bras. farmacogn.. Publicado em: 2019-02
-
5. Guillain-Barré syndrome in a patient on adalimumab for the treatment of psoriasis
Abstract The use of TNF-α inhibitors for the treatment of moderate to severe psoriasis and psoriatic arthritis is increasingly more frequent. The authors report a case of Guillain-Barré syndrome as a late manifestation of the treatment with adalimumab. Although unusual, this is relevant for professionals who prescribe biologic drugs. We also stress the imp
An. Bras. Dermatol.. Publicado em: 2017
-
6. The use of a biocompatible cement in endodontic surgery. A randomized clinical trial 1
ABSTRACT PURPOSE: To evaluate the clinical applicability of Pozzolana Biologic Silva cement (PBS(r)) in endodontic surgery. METHODS: Persistent apical periodontitis was diagnosed in 30 teeth of 12 patients by cone-beam computed tomography (CT). All patients had 2 or 4 affected teeth and underwent endodontic surgery with root-end filling. Patients with 2
Acta Cir. Bras.. Publicado em: 2016-06
-
7. Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas disease
AbstractThere are several studies on the benefits of using TNFα antagonists in the treatment of psoriasis, but few studies addressing the interaction of these drugs with chronic infections. We report the case of a 52-year-old patient diagnosed with psoriasis refractory to traditional systemic agents, who was treated with biologic therapies. After one year o
An. Bras. Dermatol.. Publicado em: 2015-06
-
8. Alopecia secondary to anti-tumor necrosis factor-alpha therapy
Biologic drugs represent a substantial progress in the treatment of chronic inflammatory immunologic diseases. However, its crescent use has revealed seldom reported or unknown adverse reactions, mainly associated with anti-tumor necrosis factor (anti-TNF). Psoriasiform cutaneous reactions and few cases of alopecia can occur in some patients while taking the
An. Bras. Dermatol.. Publicado em: 2015-04
-
9. Two cases of renal cell cancer during immunobiologic therapy for psoriasis
Immunobiologic therapy is indicated for severe forms of psoriasis, resistant to conventional therapy. There is growing concern about their safety profile and possible association with cancer development. This article documents two cases of renal cell cancer during treatment with biologic therapy, reviewing what is described in the literature . The risk of so
An. Bras. Dermatol.. Publicado em: 2014-12
-
10. Study of the influence of acid etching treatments on the superficial characteristics of Ti
Modifications in texture and surface chemistry are commonly used to increase the biologic response to implants. We evaluated the influence of five different acid etching treatments on the chemical and topographical superficial characteristics of cpTi grade IV discs (test groups). One group of samples were only polished (control group). The samples were analy
Mat. Res.. Publicado em: 01/04/2014
-
11. Alopecia universalis during treatment with leflunomide and adalimumab - Case report
Alopecia areata is a non-scarring form of alopecia that can be localized or widespread. Its etiology is unknown, but immunological factors are implicated in its pathogenesis. With the more frequent use of anti TNFα biologic drugs, some alopecia areata cases during their use have been described. We report a case of universal alopecia in a patient with rheuma
An. Bras. Dermatol.. Publicado em: 2014-04
-
12. Remoção de matéria orgânica de águas residuárias com elevada concentração de sulfato pelas vias sulfetogênica e metanogênica combinadas / Organic matter removal from wastewater with high sulphate concentration by sulphidogenic and methanogenic combined pathways
A utilização da tecnologia anaeróbia para tratamento de águas residuárias contendo sulfato foi considerada inadequada até o final da década de 1980, principalmente pela geração de odor desagradável, potencial corrosivo e pela instabilidade causada aos organismos envolvidos no processo de degradação de matéria orgânica. Entretanto, a remoção s
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 28/09/2012